Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8287857 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

October 16, 2012

Patent Application Number

13178644

Date Filed

July 8, 2011

Patent Citations Received

US Patent 12121541 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

0

US Patent 12024718 Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

0

US Patent 12090200 Methods of producing cells resistant to HIV infection

0

US Patent 12104172 Processes for generating TIL products enriched for tumor antigen-specific t-cells

0

US Patent 11713446 Processes for generating TIL products enriched for tumor antigen-specific T-cells

0

US Patent 11767510 Devices and methods for isolating tumor infiltrating lymphocytes and uses thereof

US Patent 11857573 Restimulation of cryopreserved tumor infiltrating lymphocytes

0

US Patent 11865140 Restimulation of cryopreserved tumor infiltrating lymphocytes

0

...

Patent Primary Examiner

Michail Belyavskyi

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8287857 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool